LOGIN  |  REGISTER
Astria Therapeutics

CareCloud to Present at the KeyBanc Life Sciences & MedTech Investor Forum

March 16, 2023 | Last Trade: US$1.25 0.01 -0.79

SOMERSET, N.J., March 16, 2023 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDP, CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, announced today that CFO, Bill Korn, will host investor meetings on March 21 and 22, 2023 at the KeyBanc Life Sciences & MedTech Investor Forum, being held virtually, and will hold a fireside chat with Scott Schoenhaus, KeyBanc’s Managing Director Equity Research, Healthcare IT, on Tuesday, March 21, 2023 at 12:00 p.m. EDT.

To view the fireside chat, please visit CareCloud’s investor relations site at ir.carecloud.com/events, and click on KeyBanc Life Sciences & MedTech Investor Forum.

To arrange a one-on-one meeting, investors can contact Lindsay Hummel of KeyBanc at This email address is being protected from spambots. You need JavaScript enabled to view it. or CareCloud’s investor relations firm ICR Westwicke at This email address is being protected from spambots. You need JavaScript enabled to view it..

About CareCloud

CareCloud (Nasdaq: CCLD, CCLDP, CCLDO) brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care while reducing administrative burdens and operating costs. Learn more about our products and services including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, telehealth and patient experience management (PXM) at www.carecloud.com.

Follow CareCloud on LinkedInTwitter and Facebook.

For additional information, please visit our website at www.carecloud.com. To view CareCloud’s latest investor presentations, read recent press releases, and listen to interviews with management, please visit ir.carecloud.com.

SOURCE CareCloud

Company Contact:
Bill Korn
Chief Financial Officer
CareCloud, Inc.
This email address is being protected from spambots. You need JavaScript enabled to view it.

Investor Contact:
Asher Dewhurst
ICR Westwicke
This email address is being protected from spambots. You need JavaScript enabled to view it.

Media Inquiries:
Alexis Feinberg
ICR Westwicke
This email address is being protected from spambots. You need JavaScript enabled to view it.

Stock Quote

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page